Outcome of COVID-19 Infection in Patients With Multiple Sclerosis Who Received Disease-Modifying Therapies: A Systematic Review and Meta-Analysis

BACKGROUND AND PURPOSE: A systematic review and meta-analysis was performed of the outcome of Coronavirus disease 2019 (COVID-19) infection in patients with multiple sclerosis (MS) who received disease-modifying therapies (DMTs). METHODS: Relevant studies published before November 2022 in the PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ning, Yu, WuHan, Sun, Mengjiao, Zhang, Wenjing, Zhou, Dan, Sun, Jing, Wang, ManXia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329925/
https://www.ncbi.nlm.nih.gov/pubmed/36929061
http://dx.doi.org/10.3988/jcn.2022.0348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329925/
https://www.ncbi.nlm.nih.gov/pubmed/36929061
http://dx.doi.org/10.3988/jcn.2022.0348

Ejemplares similares